VIRGIMYCINE Meaning and
Definition
-
Virgimycine is an antibiotic drug that belongs to the class of glycopeptide antibiotics. It is primarily used for its bactericidal properties against various gram-positive bacteria, including Staphylococcus aureus and Streptococcus pneumoniae. Virgimycine works by inhibiting bacterial cell wall synthesis, specifically by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors, resulting in the inhibition of peptidoglycan polymerization and thus preventing bacterial growth and replication.
Virgimycine is often administered intravenously due to its poor oral absorption. It is commonly prescribed for the treatment of severe bacterial infections that do not respond to other antibiotics, such as infections caused by methicillin-resistant Staphylococcus aureus (MRSA). As a potent antibiotic, virgimycine is typically reserved for life-threatening infections or cases where other treatment options have failed.
The use of virgimycine may be associated with certain adverse effects, including nephrotoxicity (kidney toxicity) and ototoxicity (hearing loss or damage to the inner ear). It is therefore closely monitored by healthcare professionals, who adjust the dosage based on the patient's renal function.
In conclusion, virgimycine is a glycopeptide antibiotic that is effective against certain gram-positive bacteria. Its mechanism of action involves inhibiting peptidoglycan synthesis, making it a valuable option for the treatment of severe infections caused by antibiotic-resistant organisms. However, due to its potential side effects, its use requires careful monitoring and consideration.
Common Misspellings for VIRGIMYCINE
- cirgimycine
- birgimycine
- girgimycine
- firgimycine
- vurgimycine
- vjrgimycine
- vkrgimycine
- vorgimycine
- v9rgimycine
- v8rgimycine
- viegimycine
- vidgimycine
- vifgimycine
- vitgimycine
- vi5gimycine
- vi4gimycine
- virfimycine
- virvimycine
- virbimycine
- virhimycine
